You are here: Industry Insights > CDMO

News List

Apeloa Pharmaceutical releases first ESG PharmaSources
May 12, 2025
Apeloa Pharmaceutical has released its first sustainability report. Apeloa’s 2024 Environmental, Social and Governance (ESG) report marks the start of continuous and responsible disclosure into the future.
Celonic Inaugurates “Next Generation” Biologics Development Center (BDC) and Pilot Plant in Basel, Switzerland Biotech Newswire
June 24, 2024
The Celonic Group, a Swiss Based Quality Biologics Contract Development and Manufacturing Organization (CDMO) today opened its “Next Generation” Biologics Development Center and Pilot Plant in Basel, Switzerland.
Vetter Wins Best Managed Companies Award 2024 PharmaSources
May 30, 2024
Vetter, a globally leading Contract Development and Manufacturing Organization (CDMO), has once again been awarded the Best Managed Companies Award, marking its fifth consecutive win.
Famous GLP-1RA Outside of the Circle, and Rapid Development of Peptide CDMO Xiaobin/PharmaSources
August 07, 2023
With the famous weight-loss drugs are famous outside of the circle, such as GLP-1RA, it has also stimulated the market's demand and concern for peptide CDMO.
Latest Trends in Pharmaceutical Industry Muhammad Asim Niazi
June 14, 2023
Recent years have seen innovation in many fields, such as software and computing.For the pharmaceutical industry, these latest trends have changed the paradigm of every field.
How to Select a CDMO for your company? Muhammad Asim Niazi
May 08, 2023
Under their guidelines and quality checks, CDMO use these resources to produce or manufacture for other pharma organizations.
The Increasing ADC+CDMO Industry Collaboration Yefenghong/PharmaSources
April 19, 2023
Recently, the heat on ADC pipeline deals is around, and the deal sizes are kept refreshing.
With First Chinese Small-molecule Oral Drug for COVID-19 Coming, What New Opportunities are Ushered in by the Relevant Industry Chain？ PharmaSources.com/Yefenghong
May 23, 2022
News about the progress of Chinese small-molecule oral antiviral drug for COVID-19 has been disclosed in recent days and the related R&D ushers in a critical point.
LOTTE BIOLOGICS Signs Antibody Manufacturing Contract with Ottimo Pharma PRNewswire
June 18, 2025
LOTTE BIOLOGICS announced on June 19, 2025 that it has signed a contract manufacturing agreement for antibody therapeutics with Ottimo Pharma
Samsung Biologics presents business updates at 2025 J.P. Morgan Healthcare Conference PRNewswire
January 15, 2025
Samsung Biologics (KRX: 207940.KS) announced its latest business achievements and 2025 outlook at the 43rd J.P. Morgan Healthcare Conference, which was held in San Francisco between January 13-16.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 29 30 Next page